Cannabis Corner: These stocks are all set for gains

Article Excerpt

First, the good news: widening cannabis legalization will eventually lead to some great business successes. The bad news is that only a few of the multitude of cannabis stocks today will pay off for investors. Consumer cannabis demand is high, but growing and distributing it across multiple markets is more difficult. With “Cannabis Corner,” we focus on quality stocks that are most likely to emerge as winners in the “Wild West” of marijuana investing. VIVO CANNABIS $0.12 (Toronto symbol VIVO; TSINetwork Rating: Speculative) (; Shares o/s: 367.1 million; Market cap: $40.8 million; TSI Cannabis Quality Rating [CQR]: ) lets you tap premium cannabis production in Canada. Vivo’s Vanluven facility in Napanee, Ontario, has now received its first import permit from Germany’s BfArM, the Federal Institute for Drugs and Medical Devices. The permit will let Vivo, through its ABcann Medicinals business, export products for sale into Germany by the end of this year. Vivo Cannabis is a speculative buy for aggressive investors. VALENS CO. $3.21…

You are trying to access subscriber-only content.

To read this article, you may subscribe or sign in.
If you are already a subscriber, log in here.

If you wish to become a subscriber, click here. Or you may enjoy access to all our publications when you become a Member of Pat McKeough's Inner Circle Pro.